T
The420Guy
Guest
One of the drug warriors' favorite arguments against state medical
marijuana laws and initiatives is that the medical use of marijuana has not
been approved by the FDA and that more scientific research must be
conducted. What they don't say is that marijuana is treated differently
than all other drugs.
The federal government, through the National Institute on Drug Abuse
(NIDA), retains a monopoly on the supply of marijuana that can be used in
FDA-approved research and has twice refuse to supply it to privately-funded
FDA-approved studies. Over two years ago the Medicinal Plant Program at
UMass Amherst applied for a license to produce marijuana for research
purposes only to be given the run around by the DEA. Finally, in July this
year the DEA officially announced the program's application. A decision is
expected shortly after the end of the public comment period on September
22, 2003.
The DEA has indicated that it probably won't approve the application so we
have to act now to stop the cycle keeping medical marijuana from sick and
dying patients.
Fax Dr. Andrea Barthwell, Deputy Director for Demand Reduction, Office of
National Drug Control Policy, urging her to recommend that the DEA approve
the UMass license:
https://actioncenter.drugpolicy.org/action/index.asp?step=2&item=11290
As a doctor and senior member of the Office of National Drug Control
Policy, Barthwell holds authority over this issue. Through news articles
she has become a vocal part of the Drug Czar's campaign against medical
marijuana. Her most recent article explicitly says that "If a substance has
the proven capacity to serve a medical purpose, then it will be accepted."
Yet, Dr Barthwell, along with the Drug Czar, continues to support the
governmental stranglehold on marijuana production hindering such research.
See Dr Barthwell's article here:
MapInc
marijuana laws and initiatives is that the medical use of marijuana has not
been approved by the FDA and that more scientific research must be
conducted. What they don't say is that marijuana is treated differently
than all other drugs.
The federal government, through the National Institute on Drug Abuse
(NIDA), retains a monopoly on the supply of marijuana that can be used in
FDA-approved research and has twice refuse to supply it to privately-funded
FDA-approved studies. Over two years ago the Medicinal Plant Program at
UMass Amherst applied for a license to produce marijuana for research
purposes only to be given the run around by the DEA. Finally, in July this
year the DEA officially announced the program's application. A decision is
expected shortly after the end of the public comment period on September
22, 2003.
The DEA has indicated that it probably won't approve the application so we
have to act now to stop the cycle keeping medical marijuana from sick and
dying patients.
Fax Dr. Andrea Barthwell, Deputy Director for Demand Reduction, Office of
National Drug Control Policy, urging her to recommend that the DEA approve
the UMass license:
https://actioncenter.drugpolicy.org/action/index.asp?step=2&item=11290
As a doctor and senior member of the Office of National Drug Control
Policy, Barthwell holds authority over this issue. Through news articles
she has become a vocal part of the Drug Czar's campaign against medical
marijuana. Her most recent article explicitly says that "If a substance has
the proven capacity to serve a medical purpose, then it will be accepted."
Yet, Dr Barthwell, along with the Drug Czar, continues to support the
governmental stranglehold on marijuana production hindering such research.
See Dr Barthwell's article here:
MapInc
